CryoLife   Report issue

For profit Phase 3 Phase 4
Founded: Kennesaw GA United States (1984)
Status: No NME R&D (1984)

Organization Overview

First Clinical Trial
2019
NCT04142658
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

CryoLife, Inc.

Active Ingredients

Drugs in Phase 4 Trials (1)

Key: CryoLife (0) Acquired (1)

vitamin d3 (1 trial)

Drugs in Phase 3 Trials (2)

apixaban (eliquis) (1 trial)

warfarin (coumadin) (1 trial)

Drugs in Other Trials (1)

Key: CryoLife (0) Acquired (1)

allogeneic bone marrow (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Aortic Valve Stenosis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 4